Healthcare Professionals click here for Risk Evaluation
and Mitigation Strategy
(REMS) Information
The information contained in this section of the site is intended for U.S. healthcare professionals only.
Are you a healthcare professional?
KALBITOR is the first subcutaneous treatment approved for all HAE attack locations in patients 16 years of age and older.
Approval based on results from two placebo-controlled phase 3 clinical studies that included:
Please see Full Prescribing Information, including Boxed Warning and Medication Guide.
If you have prescribed or administered KALBITOR, we request your feedback. Click here to learn about the survey and related compensation.
CALL TOLL-FREE (1-888-452-5248) 1-888-4Kalbitor
to reach our KALBITOR Access specialists
24 hours a day, 7 days a week
TO START YOUR PATIENTS ON KALBITOR In 2 simple steps you can prescribe KALBITOR and set up your patients with customized support services through KALBITOR Access.
KALBITOR Access Start Form (PDF) KALBITOR Access Patient Authorization Form (PDF)